Skip to main content Skip to search Skip to main navigation

What is a Contamination Control Strategy (CCS) and what does it include?

According to the new Annex 1 (2022), a Contamination Control Strategy (CCS) must be implemented for the entire cleanroom and controlled environment system of the facility. This must define the cleanliness zone concepts with all critical control points and evaluate the effectiveness of all design, procedural, technical and organisational controls and monitoring measures used to manage the risks associated with contamination.

[GMP Compliance Adviser, Chapter 5.D]

You can find the whole new chapter 12.B on this topic in the GMP Compliance Adviser.

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

What are the quality requirements for pharmaceutical gases?

What are the quality requirements for pharmaceutical gases?

You can view the answer here:
Read more
EMA: Update on the Guideline “Stability Testing for Variations”

EMA: Update on the Guideline “Stability Testing for Variations”

The EMA has updated the guideline on stability testing for variations (Revision 3, applicable from 15 January 2026).
Read more
EU: Proposal for Simplification of Medical Device Rules

EU: Proposal for Simplification of Medical Device Rules

The European Commission has proposed targeted reforms to simplify the Medical Device Regulation (Regulation (EU) 2017/745, MDR) and the In Vitro Diagnostic Regulation (Regulation (EU) 2017/746, IVDR) and to address structural implementation challenges.
Read more
Previous
Next